The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Uric Acid and Incident Kidney Disease in the Community
Open accessAbstract
Uric acid may mediate aspects of the relationship between hypertension and kidney disease via renal vasoconstriction and systemic hypertension. To investigate the relationship between uric acid and subsequent reduced kidney function, limited-access data of 13,338 participants with intact kidney function in two community-based cohorts, the Atherosclerosis Risks in Communities and the Cardiovascular Health Study, were pooled. Mean baseline serum uric acid was 5.9 +/- 1.5 mg/dl, mean baseline serum creatinine was 0.9 +/- 0.2 mg/dl, and mean baseline estimated GFR was 90.4 +/- 19.4 ml/min/1.73 m(2). During 8.5 +/- 0.9 yr of follow-up, 712 (5.6%) had incident kidney disease defined by GFR decrease (>or=15 ml/min/1.73 m(2) with final GFR <60 ml/min/1.73 m(2)), while 302 (2.3%) individuals had incident kidney disease defined by creatinine increase (>or=0.4 mg/dl with final serum creatinine >1.4 mg/dl in men and 1.2 mg/dl in women). In GFR- and creatinine-based logistic regression models, baseline uric acid level was associated with increased risk for incident kidney disease (odds ratio 1.07 [95% confidence interval 1.01 to 1.14] and 1.11 [95% confidence interval 1.02 to 1.21] per 1-mg/dl increase in uric acid, respectively), after adjustment for age, gender, race, diabetes, systolic BP, hypertension, cardiovascular disease, left ventricular hypertrophy, smoking, alcohol use, education, lipids, albumin, hematocrit, baseline kidney function and cohort; therefore, elevated serum uric acid level is a modest, independent risk factor for incident kidney disease in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Self-citationThe Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
(1989) · PubMed · Cited by 3,139
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
Kurella, M., Lo, J. C., & Chertow, G. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010106 · Cited by 709
Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia
Choi, H. K., & Ford, E. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.040 · Cited by 601
Shlipak, M. G., Katz, R., Sarnak, M. J., Fried, L. F., Newman, A. B., Stehman-Breen, C., Seliger, S. L., Kestenbaum, B., Psaty, B., Tracy, R. P., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00003 · Cited by 540
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
Iseki, K., Ikemiya, Y., Inoue, T., Iseki, C., Kinjo, K., & Takishita, S. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)00934-5 · Cited by 526
Masuo, K., Kawaguchi, H., Mikami, H., Ogihara, T., & Tuck, M. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000091371.53502.d3 · Cited by 516
Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents
Ford, E. S., Li, C., Cook, S., & Choi, H. K. (2007) · Circulation · doi:10.1161/circulationaha.106.657627 · Cited by 497
Relationship of Uric Acid With Progression of Kidney Disease
Chonchol, M., Shlipak, M. G., Katz, R., Sarnak, M. J., Newman, A. B., Siscovick, D. S., Kestenbaum, B., Carney, J. K., & Fried, L. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.013 · Cited by 420
ISEKI, K., OSHIRO, S., TOZAWA, M., ISEKI, C., IKEMIYA, Y., & TAKISHITA, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.691 · Cited by 386
Weiner, D. E., Tabatabai, S., Tighiouart, H., Elsayed, E., Bansal, N., Griffith, J., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.05.021 · Cited by 325
Self-citationMild hyperuricemia induces glomerular hypertension in normal rats
Sánchez-Lozada, L. G., Tapia, E., Avila-Casado, C., Soto, V., Franco, M., Santamaría, J., Nakagawa, T., Rodríguez-Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00170.2002 · Cited by 297
Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome
Krishnan, E., Kwoh, C. K., Schumacher, H. R., & Kuller, L. (2007) · Hypertension · doi:10.1161/01.hyp.0000254480.64564.b6 · Cited by 293
Ishani, A., Grandits, G. A., Grimm, R. H., Svendsen, K. H., Collins, A. J., Prineas, R. J., & Neaton, J. D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005091012 · Cited by 272
Cardiovascular Disease and Subsequent Kidney Disease
Elsayed, E. F., Tighiouart, H., Griffith, J., Kurth, T., Levey, A. S., Salem, D., Sarnak, M. J., & Weiner, D. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1130 · Cited by 255
Self-citationWeiner, D. E., Tighiouart, H., Vlagopoulos, P. T., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070597 · Cited by 208
Self-citationUric Acid, the Metabolic Syndrome, and Renal Disease
Cirillo, P., Sato, W., Reungjui, S., Heinig, M., Gersch, M., Sautin, Y., Nakagawa, T., & Johnson, R. J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080909 · Cited by 203
Edwards, M. S., Wilson, D. B., Craven, T. E., Stafford, J., Fried, L. F., Wong, T. Y., Klein, R., Burke, G. L., & Hansen, K. J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.005 · Cited by 194
Plasma Uric Acid Level and Risk for Incident Hypertension Among Men
Forman, J. P., Choi, H., & Curhan, G. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080865 · Cited by 181
Area Socioeconomic Status and Progressive CKD: The Atherosclerosis Risk in Communities (ARIC) Study
Merkin, S. S., Coresh, J., Roux, A. V. D., Taylor, H. A., & Powe, N. R. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.033 · Cited by 139
Odden, M. C., Chertow, G. M., Fried, L. F., Newman, A. B., Connelly, S., Angleman, S. B., Harris, T. B., Simonsick, E. M., Shlipak, M. G., & Study, F. T. H. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj333 · Cited by 107
Feig, D. I., Rodríguez‐Iturbe, B., Nakagawa, T., & Johnson, R. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000223447.53155.d5 · Cited by 31
Cited by
Elevated Uric Acid Increases the Risk for Kidney Disease
Obermayr, R. P., Temml, C., Gutjahr, G., Knechtelsdorfer, M., Oberbauer, R., & Klauser-Braun, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010080 · Cited by 647
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Badve, S. V., Pascoe, E. M., Tiku, A., Boudville, N., Brown, F. G., Cass, A., Clarke, P., Dalbeth, N., Day, R. O., de Zoysa, J. R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915833 · Cited by 473
The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging
Denic, A., Lieske, J. C., Chakkera, H. A., Poggio, E. D., Alexander, M. P., Singh, P., Kremers, W. K., Lerman, L. O., & Rule, A. D. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020154 · Cited by 452
Uric Acid and Long-term Outcomes in CKD
Madero, M., Sarnak, M. J., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.12.021 · Cited by 436
Self-citationHyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Borghi, C., Agabiti-Rosei, E., Johnson, R. J., Kielstein, J. T., Lurbe, E., Mancia, G., Redon, J., Stack, A. G., & Tsioufis, K. P. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.07.006 · Cited by 435
Metadata
- Authors
- Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., & Levey, A. S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2008-06
- Volume
- 19
- Issue
- 6
- Pages
- 1204-1211
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2169831409
- Cited by
- 462
- References
- 27
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.